Product image of Metformina + Sitagliptina Tolife (Metformin Hydrochloride, Sitagliptin) supplied by GNH India

Metformina + Sitagliptina Tolife

Active Ingredient:
Metformin Hydrochloride, Sitagliptin
Origin:
EU

Metformina + Sitagliptina Tolife (Metformin Hydrochloride, Sitagliptin)

Metformin Hydrochloride, the active ingredient in Metformina + Sitagliptina Tolife, is a biguanide presented as a tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus, often in combination with other antidiabetic agents.

GNH India supplies Metformina + Sitagliptina Tolife as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable delivery.

Manufacturer / TM Owner

Towa Pharmaceutical S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformina + Sitagliptina Tolife combines metformin and sitagliptin to manage hyperglycemia in type 2 diabetes.

  • Type 2 diabetes mellitus: lowers fasting and post‑prandial glucose levels.
  • Inadequate glycemic control with metformin alone: provides additional DPP‑4 inhibition to achieve target HbA1c.
  • Combination therapy with insulin: reduces required insulin dose while maintaining glucose control.

How It Works

  • Metformin decreases hepatic gluconeogenesis and enhances peripheral insulin sensitivity, while sitagliptin inhibits the dipeptidyl peptidase‑4 enzyme, prolonging the activity of incretin hormones (GLP‑1 and GIP) that increase glucose‑dependent insulin secretion and suppress glucagon release, together improving overall blood glucose regulation.

Side Effects

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea.
  • Headache: mild to moderate intensity.
  • Mild hypoglycemia: especially when used with sulfonylureas or insulin.
  • Metallic taste: transient alteration in taste perception.
  • Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic complication.
  • Severe hypoglycemia: prolonged low blood glucose levels.
  • Pancreatitis: inflammation of the pancreas presenting with abdominal pain.
  • Allergic reactions: rash, itching, or angioedema.
  • Hepatic dysfunction: elevated liver enzymes.
  • Renal impairment: worsening kidney function, particularly in high‑risk patients.

Precautions & Warnings

Precautions should be observed when prescribing Metformina + Sitagliptina Tolife.

  • Renal function: assess eGFR before initiating and monitor periodically.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Lactic acidosis risk: avoid in patients with hypoxia, heart failure, or severe infection.
  • Pregnancy: safety not established; weigh benefits against potential risks.
  • Drug interactions: review concomitant medications for possible interactions.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Metformina + Sitagliptina Tolife may interact with several medicines.

Major Interactions (Avoid)

  • Severe renal impairment: contraindicated due to risk of metformin accumulation.
  • Iodinated contrast agents: may precipitate acute kidney injury, increasing metformin levels.
  • Strong CYP2C8 inhibitors: can raise metformin plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Sulfonylureas: increased risk of hypoglycemia; monitor blood glucose.
  • Insulin: may require dose adjustment to prevent hypoglycemia.
  • Diuretics: can affect renal clearance of metformin; monitor renal function.

Frequently Asked Questions

Metformina + Sitagliptina Tolife is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus, particularly when diet, exercise, and monotherapy with metformin are insufficient.

Metformin Hydrochloride reduces hepatic glucose production and increases peripheral insulin sensitivity, helping lower fasting blood glucose levels and improve overall glycemic control.

Sitagliptin inhibits the DPP‑4 enzyme, which prolongs the activity of incretin hormones (GLP‑1 and GIP). This enhances glucose‑dependent insulin secretion and suppresses glucagon release after meals.

The appropriate dose is determined by the prescribing healthcare professional based on individual patient factors such as renal function, glycemic targets, and concomitant therapies.

Safety in pregnancy and lactation has not been established. The prescriber should evaluate potential benefits against possible risks before use in these populations.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Compared with metformin alone, the addition of sitagliptin offers complementary glucose‑lowering mechanisms, often achieving better HbA1c reduction without the weight gain associated with some other agents such as sulfonylureas or insulin.

Store the tablets at ambient temperature, below 25 °C, in the original container, protected from moisture and direct sunlight to maintain product stability.

The medication is taken orally, usually with meals, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include lactic acidosis from metformin, especially in patients with renal or hepatic impairment, and rare cases of pancreatitis or severe hypoglycemia when combined with insulin or sulfonylureas.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride, Sitagliptin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT